Time to Sustained Improvement in Bowel Movement Frequency With Telotristat Ethyl: Analysis of the Phase 3 TELESTAR Study

Dillon JS, Kulke MH, Pavel ME, Horsch D, Anthony LB, Warner RRP, Bergsland E, Welin S, O'Dorisio TM, Patel N, Lapuerta P (2018)

Publication Type: Conference contribution

Publication year: 2018

Journal

Pancreas Lippincott, Williams & Wilkins

Book Volume: 47

Pages Range: 337-338

Journal Issue: 3

Authors with CRIS profile

Marianne Ellen Pavel Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

Involved external institutions

University of California San Francisco (UCSF)

United States (USA) (US) University of Kentucky

United States (USA) (US) University of Iowa

United States (USA) (US) Uppsala University Hospital / Akademiska sjukhuset

Sweden (SE) Lexicon Pharmaceuticals, Inc.

United States (USA) (US) Dana–Farber Cancer Institute

United States (USA) (US) Zentralklinikum Bad Berka

Germany (DE) Icahn School of Medicine at Mount Sinai

United States (USA) (US)

How to cite

APA:

Dillon, J.S., Kulke, M.H., Pavel, M.E., Horsch, D., Anthony, L.B., Warner, R.R.P.,... Lapuerta, P. (2018). Time to Sustained Improvement in Bowel Movement Frequency With Telotristat Ethyl: Analysis of the Phase 3 TELESTAR Study. (pp. 337-338).

MLA:

Dillon, Joseph S., et al. "Time to Sustained Improvement in Bowel Movement Frequency With Telotristat Ethyl: Analysis of the Phase 3 TELESTAR Study." 2018. 337-338.

BibTeX: Download